Locomotor Experience Applied Post Stroke Trial (LEAPS)

July 9, 2014 updated by: Duke University

Locomotor Experience Applied Post Stroke (LEAPS) Trial

The purpose of this study is to compare two different treatments to improve walking after stroke (or post-stroke).

Study Overview

Detailed Description

The impact of stroke on walking is significant, with only 37 percent of stroke survivors able to walk after the first week after stroke (or post-stroke). Even among those who achieve independent ambulation, significant residual deficits persist in balance and gait speed with a 73 percent incidence of falls among individuals with mild to moderate impairment 6 months post-stroke. Body weight supported treadmill training is one therapeutic method for locomotor training that is rapidly being adopted into physical rehabilitation to improve walking after stroke.

The purpose of this multi-center, randomized controlled study is to compare two different treatments to improve walking after stroke. The two treatments are: 1) a training program that includes use of a body weight support system and a treadmill to practice walking and 2) a physical therapist monitored exercise program to work on general conditioning and strengthening in the patient's home. In addition, investigators will determine the best time to provide training after a stroke and if the training is beneficial for mild, moderate, or severe cases of stroke.

Four hundred subjects will be recruited from five facilities in Florida and California. Screening and subject recruitment will take place within 45 days post-stroke. All stroke patients will be screened to determine eligibility for the study. Eligible subjects will be followed for 2 months post-stroke. At that time, those who are eligible for enrollment and who consent to participate will undergo an exercise tolerance test and baseline assessment. Following this evaluation, participants will be randomized into one of three groups, according to the severity of their locomotor impairment: early locomotor, late locomotor, or early home exercise.

The early locomotor training group will begin the locomotor training program immediately (2 months post stroke). The locomotor training program is an out-patient program of locomotor training for 36 sessions, 3 times per week, using a body weight support system and stepping on a treadmill. The late locomotor training group will begin locomotor training at 6 months post-stroke. Participants in the early home exercise group will receive a non-specific low intensity exercise program beginning immediately (2 months post stroke).

Study Type

Interventional

Enrollment (Actual)

408

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Inglewood, California, United States
        • Centinela Freeman Memorial Hospital
      • Long Beach, California, United States
        • Long Beach Memorial Hospital
      • Los Angeles, California, United States
        • University of Southern California - PT Associates
      • San Diego, California, United States
        • Sharp Memorial Rehabilitation Center
    • Florida
      • Gainesville, Florida, United States
        • University of Florida
      • Jacksonville, Florida, United States
        • Brooks Rehabilitation Hospital
      • Orlando, Florida, United States
        • Florida Hospital
    • North Carolina
      • Durham, North Carolina, United States
        • Duke University (Administrative Coordinating Center)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age >/=18
  • Stroke within 45-days
  • Residual paresis in the lower extremity (fugl-meyer le motor score < 34)
  • Ability to sit unsupported for 30 seconds
  • Ability to walk at least 10 feet with maximum 1 person assist
  • Ability to follow a three step command
  • Provision of informed consent
  • A self-selected 10 meter gait speed less than 0.8 m/s at the 2-month post-stroke assessment
  • Successful completion of an exercise tolerance test

Exclusion Criteria:

  • Lived in nursing home prior to stroke
  • Unable to ambulate at least 150 feet prior to stroke, or experienced intermittent claudication while walking less than 200 meters
  • Serious cardiac conditions (history of congestive heart failure, documented serious and unstable cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, angina or dyspnea at rest or during activities of daily living). Anyone meeting New York Heart Association criteria for Class 3 or Class 4 heart disease will be excluded
  • History of serious chronic obstructive pulmonary disease or oxygen dependence
  • Severe weight bearing pain
  • Preexisting neurological disorders such as Parkinson's disease, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), dementia, or previous stroke with residual neurological deficits
  • History of major head trauma
  • Lower extremity amputation
  • Non-healing ulcers on the lower extremity
  • Renal dialysis or end stage liver disease
  • Legal blindness or severe visual impairment
  • A history of significant psychiatric illness defined by diagnosis of bipolar affective disorder, psychosis, schizophrenia or medication refractory depression
  • Life expectancy less than one year
  • Severe arthritis or orthopedic problems that limit passive ranges of motion of lower extremity (knee flexion contracture of -10°, knee flexion Range of Motion (ROM) < 90°, hip flexion contracture > 25°, and ankle plantar flexion contracture > 15°
  • History of sustained alcoholism or drug abuse in the last six months
  • Major post-stroke depression as measured by the Patient Health Questionnaire(PHQ-9 >/= 10) that is not medically managed with antidepressant medication and/or psychotherapy
  • History of pulmonary embolism within 6 months
  • Uncontrollable diabetes with recent weight loss, diabetic coma, or frequent insulin reactions
  • Severe hypertension with systolic greater than 200 mmHg and diastolic greater than 110 mmHg at rest,
  • Previous or current enrollment in a clinical trial to enhance stroke motor recovery
  • Lives more than 50 miles from the training sites
  • Unable to travel 3 times per week for outpatient training programs
  • Intracranial hemorrhage related to aneurysmal rupture or an arteriovenous malformation (hemorrhagic infarctions will not be excluded)

Inclusion and exclusion criteria will be determined by a chart review, depression screen and subject interview by study physician or study coordinator. After initial chart and subject interview, each subject's treating physician will be asked to review inclusion and exclusion criteria and provide a letter supporting inclusion in the study. All subjects who meet selection criteria must successfully complete an exercise tolerance test

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Early Locomotor Training Program
body weight supported training program with treadmill
The early locomotor training program is an out-patient program of locomotor training for 36 sessions, 3 times per week, using a body weight support system and stepping on a treadmill and overground training beginning at 2 months post-stroke.
Other Names:
  • E-LTP
  • LTP-early
ACTIVE_COMPARATOR: Late Locomotor Training Program
body weight supported training program with treadmill
The late locomotor training program is an out-patient program of locomotor training for 36 sessions, 3 times per week, using a body weight support system and stepping on a treadmill and overground training beginning at 6 months post-stroke.
Other Names:
  • L-LTP
  • LTP-late
ACTIVE_COMPARATOR: Early Home Exercise Program
a non-specific low intensity exercise program
Participants in the early home exercise group will receive a non-specific low intensity exercise program beginning at 2 months post stroke.
Other Names:
  • HEP

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage of Patients Who Successfully Improved Functional Level of Walking at 1 Year Post-stroke
Time Frame: 12 months post-stroke
Success: walking greater than 0.4 m/sec if baseline was less than 0.4; walking greater than 0.8 m/sec if baseline was 0.4m/sec or greater but less than 0.8 m/sec as measured during 10 meter walk.
12 months post-stroke
Walking Speed: Measured During a 10-meter Walk
Time Frame: Baseline and 12 months post-stroke
Baseline and 12 months post-stroke

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage of Patients Who Successfully Improved Functional Level of Walking at 6 Months Post-stroke
Time Frame: Baseline and 6 months post-stroke
Success: walking greater than 0.4 m/sec if baseline was less than 0.4; walking greater than 0.8 m/sec if baseline was 0.4m/sec or greater but less than 0.8 m/sec as measured during 10 meter walk.
Baseline and 6 months post-stroke
6 Month Outcome: Walking Speed: Measured During a 10-meter Walk
Time Frame: Baseline and 6 months post-stroke
Baseline and 6 months post-stroke
6 Minute Walking Distance (Meters)
Time Frame: Baseline, 6 months and 12 months post-stroke
Distance walked in 6 minutes.
Baseline, 6 months and 12 months post-stroke
Step Activity Monitor (SAM)- Median of Average Number of Steps Per Day
Time Frame: Baseline, 6 months and 12 months post-stroke
As measured with a step activity monitor averaged over 2 days.
Baseline, 6 months and 12 months post-stroke
Stroke Impact Scale (SIS) - Participation
Time Frame: Baseline, 6 months and 12 months post-stroke
Range = 0 - 100. The Stroke Impact Scale is a measure of function (including ADL-IADL and mobility) and quality of life (participation). The Participation Scale is a single domain of the Stroke Impact Scale in which participation is defined as the ability to engage in meaningful activities with 0 indicating inability to engage in any meaningful activities and 100 indicating the ability to fully engage in meaningful activities.
Baseline, 6 months and 12 months post-stroke
Stroke Impact Scale (SIS) - Activities of Daily Living/Instrumental Activities of Daily Living (ADL/IADL)
Time Frame: Baseline, 6 months and 12 months post-stroke
Range 0 - 100 The Stroke Impact Scale (SIS) is a measure of function including ADL/IADL. The ADL/IADL scale is a single domain of the Stroke Impact Scale in which ADL is defined as the ability to take care of basic needs and IADL is defined as the ability to perform activities that make it possible to live independently in the community, with 0 indicating complete dependence on others and 100 indicating the ability to live independently without difficulty.
Baseline, 6 months and 12 months post-stroke
Stroke Impact Scale (SIS) - Mobility
Time Frame: Baseline, 6 months and 12 months post-stroke
Range = 0 - 100. The Stroke Impact Scale (SIS) is a measure of function including Mobility. The Mobility scale is a single domain of the Stroke Impact Scale which captures the ability to balance and move, with 0 indicating severe restrictions in balance and mobility and 100 indicating independence in mobility and balance.
Baseline, 6 months and 12 months post-stroke
Fugl-Meyer Lower Extremity Score
Time Frame: Baseline, 6 months and 12 months post-stroke
Range 0 - 34 The Fugl-Meyer Lower Extremity Score measures your ability to move the lower extremity with 0 indicating no movement and 34 indicating the ability to selectively move the lower extremity without difficulty.
Baseline, 6 months and 12 months post-stroke
Berg Balance Score
Time Frame: Baseline, 6 months and 12 months post-stroke
Range = 0 - 56 The Berg Balance Score assesses balance in sitting, standing, reaching, shifting weight and turning, with 0 defined as inability to balance and 56 defined as the ability to balance independently and without difficulty while performing each task.
Baseline, 6 months and 12 months post-stroke
Activities Specific Balance Confidence (ABC) Score
Time Frame: Baseline, 6 months and 12 months post-stroke
Range = 0 - 100 The ABC scale is a self reported measure of confidence with activities such as walking around the house, standing on a chair to reach or getting out of a car without losing balance or becoming unsteady. A score of 0 indicates no confidence that the activities can be performed without losing balance and a score 100 indicates confidence that the activities can be accomplished without losing balance.
Baseline, 6 months and 12 months post-stroke

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Pamela W. Duncan, PhD, PT, FAPTA, FAHA, Professor and Bette Busch Maniscalco, Doctor of Physical Therapy Division, Research Fellow, Department of Community and Family Medicine, Duke Center for Clinical Health Policy Research
  • Principal Investigator: Katherine J. Sullivan, Ph.D., PT, Co-Principal Investigator, Division of Biokinesiology and Physical Therapy, University of Southern California, Los Angeles, California
  • Principal Investigator: Andrea L. Behrman, Ph.D., PT, Co-Principal Investigator, Department of Physical Therapy, Brooks Center for Rehabilitation Studies, University of Florida, and Department of Veteran Affairs Brain Rehabilitation Research Center, Gainesville, Florida
  • Study Director: Stanley P. Azen, Ph.D.,, Director Data Management Core, Biostatistics Division, Department of Preventive Medicine, University of Southern California, Los Angeles, California
  • Study Director: Samuel S. Wu, Ph.D., Lead Biostatistician - Investigator, Department of Epidemiology and Health Policy Research, University of Florida
  • Study Director: Bruce H. Dobkin, MD, Investigator, Department of Neurology, University of California, Los Angeles, California
  • Study Director: Stephen E. Nadeau, MD, Investigator, Geriatric Research, Education and Clinical Center and the Brain Rehabilitation Research Center, Gainesville VA Medical Center, and the Department of Neurology, University of Florida College of Medicine, Gainesville, Fl

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2006

Primary Completion (ACTUAL)

April 1, 2010

Study Completion (ACTUAL)

June 1, 2012

Study Registration Dates

First Submitted

October 24, 2005

First Submitted That Met QC Criteria

October 24, 2005

First Posted (ESTIMATE)

October 25, 2005

Study Record Updates

Last Update Posted (ESTIMATE)

July 16, 2014

Last Update Submitted That Met QC Criteria

July 9, 2014

Last Verified

December 1, 2012

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Early locomotor training program

3
Subscribe